Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial

Andrea Russo, Nicolò Scaroni, Elena Gambicorti, Raffaele Turano, Francesco Morescalchi, Ciro Costagliola, Francesco Semeraro
  • Clinical Ophthalmology, March 2018, Dove Medical Press
  • DOI: 10.2147/opth.s159672

ranibizumab and indomethacin in neovascular age-related macular degeneration

The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Francesco Semeraro